TE_27261
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MER61A |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 170.19 |
| Counts of samples | TCGA_tumor:150; TCGA_normal:0; GTEx:0 |
| TSS | chr13(-):61671419 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_27261.11 | - | Intergenic | Non-coding | Non-coding | chr13(-):61667220,61667240,61671207,61671420 |
| teRNA_27261.12 | - | Intergenic | Non-coding | Non-coding | chr13(-):61666925,61666945,61667120,61667240,61671207,61671420 |
| teRNA_27261.13 | - | Intergenic | Non-coding | Non-coding | chr13(-):61668588,61668608,61671207,61671420 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
